Delphi Consulting Group (DCG)
Medical Device regulatory service company that is Internet Based
Regulatory Assistance with medical devices and the U.S. FDA.
Delphi Consulting Group (DCG) provides U.S. Food and Drug Administration release to market for medical device companies. DCG was formed in 1987.
Please take a few minutes and review the regulatory services we provide. DCG maximizes the Internet to provide fast response, reduce travel and provide reasonable costs. With the simplest of tools, such as Skype, Skype video, and / or other teleconference systems and with share computer screens software the cost of travel can be reduced to zero.
DCG is a boutique US FDA regulatory assistance firm serving worldwide medical device manufactures with product release to market in the US, Good Manufacturing Practices [GMP], documentation, acting as US Agent, and other FDA interface requirements. Our small size and low overhead costs allow us to provide prompt response to needs, with equitable overall costs. DCG's client base is worldwide.
Delphi Consulting Group's mission is to make our clients regulatory needs as simple and transparent as possible.
DCG always works to ensure complete compliance with all required regulations and laws.
DCG works to provide billing hours at a fixed price or Not to Exceed (NtE), cost budgets for some projects.
DCG always works to ensure regulatory compliance and seeks only those clients that share the same end results.
DCG operates under Regulatory Affairs Professional Society's Code of Ethics.
DCG works to span the bridge between your regulatory needs and all applicable regulatory requirements.
DCG works to keep your FDA regulatory submission costs very low.
Delphi Consulting (DCG) is a consulting company specializing in U.S. Food and Drug Administration medical device release to market.
DCG was established in the year 1987.
DCG's client base is world wide.
Services include but not limited to the following:
Company principal is James Harvey Knauss. For c.v. click here.
Send mail to
questions or comments about this web site.